Sino Biological Newly Launched A Panel of Research Reagents for SARS-CoV-2 Omicron Variant (B.1.1.529) Beijing, China, December 6th, 2021 – Sino Biological, Inc. (https://www.sinobiological.com, SHE: ...

Sino Biological’s new Omicron product line includes recombinant Omicron Spike proteins (RBD, S1, and S-ECD trimer), monoclonal antibodies recognizing the Omicron Spike protein, and the Omicron ...

China, August 16, 2021 - Sino Biological, Inc. (“Sino Biological” or the “Company”), a biotechnology company which provides biological research reagents and related technical contract research ...

Recent reports of Nipah virus (NiV) infections in West Bengal, India, have reignited global concern, prompting public health authorities to prioritize research into this high-mortality pathogen. In ...

Sino Biological, a biotechnology company which provides biological research reagents and related technical contract research services, announced a successful listing on the Shenzhen Stock Exchange ...

RESEARCH TRIANGLE, N.C.--(BUSINESS WIRE)--JAGGAER, the global leader in Autonomous Commerce, is collaborating with CiteAb, a UK-based provider of high-quality life science data, to enable researchers ...

insights from industryDr. Zhang Lin LinTechnical SpecialistSino Biological Europe In this interview, News-Medical talks to Dr. Zhang Linlin, Technical Specialist at Sino Biological Europe, about their ...

SHANGHAI (Reuters) -Pharmaceutical research and development firms in China are increasingly interested in procuring critical supplies known as reagents from local manufacturers, industry executives ...

Measuring TNF-α accurately sounds straightforward until researchers begin comparing data across experiments. Serum and plasma matrices can affect cytokine recovery. Low-abundance samples may approach ...

Sino Biological, Inc. announced today that it has launched a panel of research reagents for the newly identified Omicron variant (B.1.1.529) of the SARS-CoV-2 virus, which quickly raised concerns ...